A phase I dose escalation of hydroxyurea (HU) in addition to continuous infusion 5-fluorouracil (5FU) in patients with advanced colorectal cancer

被引：0
|
作者：
Last, K [1 ]
Lofts, FJ [1 ]
Thompson, F [1 ]
Mansi, JL [1 ]
机构：
[1] St Georges Healthcare NHS Trust, Dept Med Oncol, London, England
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP71
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [21] Adjuvant therapy with 5-fluorouracil (5FU) plus levamisole or 5FU plus radiotherapy in resected colorectal cancer.
    Aparicio, J
    Segura, A
    Santaballa, A
    Garcerá, S
    Yuste, A
    López, P
    Tormo, A
    Reynés, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S78 - S78
  • [22] ACTIVITY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER CLINICALLY RESISTANT TO BOLUS 5-FLUOROURACIL
    MORI, A
    BERTOGLIO, S
    GUGLIELMI, A
    ASCHELE, C
    BOLLI, E
    TIXI, L
    ROSSO, R
    SOBRERO, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (02) : 179 - 180
  • [23] 5FU Continuous Infusion in Heavily Pretreated Advanced Breast Cancer Patients
    Regierer, Anne C.
    Reinecke, Franziska
    Weigel, Andrea
    Dieing, Annette
    Lehenbauer-Dehm, Silvia
    Schwarzlose-Schwarck, Sandra
    Possinger, Kurt
    Eucker, Jan
    ONKOLOGIE, 2011, 34 (12): : 696 - 700
  • [24] The impact of sarcopenia on toxicity and pharmacokinetics of 5-fluorouracil (5FU) in colorectal cancer.
    Williams, Grant Richard
    Deal, Allison Mary
    Shachar, Shlomit S.
    Walko, Christine Marie
    Patel, Jai Narendra
    O'Neil, Bert H.
    McLeod, Howard L.
    Weinberg, Marc
    Choi, Seul Ki
    Muss, Hyman B.
    Sanoff, Hanna Kelly
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [25] A phase I study of oxaliplatin (OXA), 5-fluorouracil (5FU) and concomitant preoperative irradiation in patients with locally advanced rectal cancer.
    Balart, J
    Marcuello, E
    Garriga, J
    Pernas, J
    Sancho, F
    González, D
    Pétriz, L
    Llaurado, J
    Martínez, A
    Guallar, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 304S - 304S
  • [26] CONTINUOUS SYSTEMIC 5-FLUOROURACIL INFUSION IN ADVANCED COLORECTAL-CANCER - RESULTS IN 91 PATIENTS
    HANSEN, R
    QUEBBEMAN, E
    AUSMAN, R
    FRICK, J
    RITCH, P
    SCHULTE, W
    HAAS, C
    BEATTY, P
    ANDERSON, T
    JOURNAL OF SURGICAL ONCOLOGY, 1989, 40 (03) : 177 - 181
  • [27] High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in elderly patients with advanced colorectal cancer
    Recchia, F
    De Filippis, S
    Saggio, G
    Rosselli, M
    Guerriero, G
    Rea, S
    ANNALS OF ONCOLOGY, 1998, 9 : 80 - 80
  • [28] Proteomics analysis of the effect of fluorouracil (5FU) and 5FU/leucovorin (LV) on colorectal cancer (CRC) in patients
    Smid, Kees
    Meijer, Erik
    Pham, Thang V.
    de Reus, Inge
    Piersma, Sander R.
    Peters, Godefridus J.
    Jimenez, Connie R.
    CANCER RESEARCH, 2015, 75
  • [29] Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer
    Se Hoon Park
    Soo-Mee Bang
    Eun Kyung Cho
    Dong Bok Shin
    Jae Hoon Lee
    Woon KI Lee
    Min Chung
    BMC Cancer, 5
  • [30] Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer
    Park, SH
    Bang, SM
    Cho, EK
    Shin, DB
    Lee, JH
    Lee, WKI
    Chung, M
    BMC CANCER, 2005, 5 (1)
12345